AzTrials
AzTrials

Spinal Cord InjuryDRIVNCT07473258

DRIV - Health Online for People With Spinal Cord Injury

A study testing DRIV Program in people with Spinal Cord Injury, run by Karolinska Institutet at 1 site in Sweden.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Spinal Cord Injury
What is being tested?
DRIV Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSweden
Study dates
1 Aug 2025to 30 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults (18 years or older) living with a long-term spinal cord injury (acquired or congenital) and "aging with the injury" (i.e., have lived many years with SCI).
  • Have registered interest in participating in the 10-week web-based health promotion program "DRIV - hälsa online för dig med ryggmärgsskada" (health online for people with SCI).
  • Able to provide informed consent and complete self-assessment questionnaires (no severe cognitive impairment that would hinder participation).
  • Sufficient Swedish language skills and internet access to participate in weekly online group sessions via video.

Who cannot join

  • Individuals with severe psychiatric conditions that would interfere with active participation in a group health program (unmanaged mental illness preventing engagement in the online sessions).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sweden1 site
  • Rehab Station Stockholm

    Stockholm

Other trials in Sweden

About this study

Official title: DRIV - Health Online for People With a Spinal Cord Injury

The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). The main questions it aims to answer are:

Does participating in the online course lead to healthier lifestyle behaviors (for example, more physical activity and a better diet) and improved self-reported health for people with SCI? Are any improvements in health habits or well-being maintained six months after completing the program?

Read more

Researchers will compare participants who take the 10-week DRIV course to those on a waitlist (no intervention during that period) to see if any changes in lifestyle or health outcomes are due to the program (and not just time or other factors).

Participants will:

Attend a 1-hour group session online (via video) each week for 10 weeks, covering topics like exercise, nutrition, stress management, and goal setting (this is the intervention for the course group; waitlist group has no sessions during this time).

Complete health questionnaires at the start of the study and after 10 weeks (all participants), and again 6 months after the course for those who received the intervention, to report on their lifestyle habits, physical and mental health, and goal achievement.

Wear a wrist activity monitor (accelerometer) for 7 days at the beginning and 7 days at the end of the 10-week period to objectively measure physical activity levels.

Read the detailed description

Overview This study evaluates the DRIV program, a 10-week web-based health-promotion course designed for individuals living long-term with spinal cord injury (SCI). The Detailed Description below outlines the study's operational procedures, design, data-collection flow, and analytic approach. It intentionally avoids content already provided in sections such as background, significance, eligibility criteria, and outcome measures.

Study Design The study uses a prospective intervention design with a waitlist control group. All individuals who register for the DRIV course are placed on a waitlist. For each course cycle, 8-12 individuals are invited to participate in that round and make up the intervention cohort. Individuals remaining on the waitlist are invited to serve as controls, with the guarantee that they will later be offered participation in a future course cycle.

Participants are not blinded to their group assignment, as the intervention consists of an educational course requiring active engagement.

Intervention Procedures

The intervention is the 10-week DRIV online course, delivered via Zoom. Each weekly session includes:

A topic-specific lecture (e.g., adapted physical activity, nutrition, stress management).

Facilitated discussions based on a study-circle model. Structured goal-setting and behavioral-change strategies. Weekly home assignments and optional adapted exercise sessions.

All course participants (regardless of research participation) receive identical program content. Study participants additionally complete standardized assessments at specified timepoints.

Control Procedures Control participants receive no intervention during their 10-week control period and continue their usual activities. They complete the same baseline and 10-week assessments as the intervention group, allowing comparison of changes over an equivalent time frame. Once their control period ends, they are offered a place in the next DRIV course but are not included again as new study controls.

Measurement Schedule

Study participants complete assessments at the following timepoints:

  • T1 (Baseline): Prior to course start (or at the equivalent time for controls).
  • T2 (10 weeks): Immediately after the intervention period (or after 10 weeks on the waitlist for controls).
  • T3 (6-month follow-up): Six months after course completion (intervention group only).

All assessments are self-administered digitally via REDCap. Participants in both groups wear an accelerometer for 7 days at T1 and T2; only intervention participants repeat this at T3.

Data Collection Procedures

  • Survey invitations are distributed individually by email with unique coded links.
  • Participants self-measure height, weight, and waist circumference using standardized written instructions.
  • Accelerometers are mailed to participants with instructions and returned for data upload.
  • All questionnaire and accelerometer data are automatically labeled with the participant's study code.

No identifiable data are stored within the analytic dataset. The code key linking identities to study codes is stored separately by the PI in secure, locked storage.

Data Management Coded data from REDCap and accelerometers are exported to a secure institutional OneDrive project folder. Only authorized research team members have access. Data integrity is monitored through routine checks for completeness, timestamp accuracy, and device-return compliance. Any discrepancies are documented and resolved prior to analysis.

Statistical Approach

Data analysis will follow these steps:

  1. Descriptive analyses Summaries of baseline characteristics and distribution checks for all continuous and categorical variables.
  2. Within-group analyses Change over time within the intervention group (T1→T2 and T1→T3) using appropriate paired methods depending on variable type and distribution.
  3. Between-group comparison at 10 weeks Comparison of change from T1→T2 between intervention and control participants to distinguish intervention-related effects from natural variation.

Exploratory analyses

  1. Associations between baseline characteristics and degree of change. Relationships between changes in different domains (e.g., self-efficacy vs. physical activity). Sensitivity analyses for missing data or partial adherence.
  2. Analyses are primarily exploratory due to the multifactorial outcome structure and modest sample size.

Sample Size Considerations The study aims to recruit approximately 30 intervention participants and 30 controls across multiple course iterations. This sample size is considered feasible and adequate for detecting meaningful changes in key behavioral and psychosocial measures based on effect sizes reported in previous SCI health-behavior studies. Recruitment continues until target numbers are achieved.

Participant Flow and Adherence Tracking Adherence to program components (session attendance, assignment completion) is recorded through weekly logs maintained by the course leader. Completion of T1-T2-T3 assessments is monitored through REDCap timestamps. Dropout or non-completion is documented with reason if provided.

Ethical and Data-Protection Procedures

All participants provide written informed consent prior to data collection. The intervention is voluntary and declining research participation does not restrict course participation.

All handling of personal data complies with GDPR and institutional policies. Risks are minimal, limited to potential discomfort reflecting on lifestyle habits or wearing an activity monitor.

Being tested
DRIV Program
Keywords
clinical trial
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DRIV ProgramBehavioural

    Also called Arm 1 Intervention

    Participants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions.

Study groups in NCT07473258
Study groupRoleWhat they receive
Arm 1: Intervention - DRIV ProgramExperimentalParticipants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions.
Receives: Behavioral: DRIV Program
Arm 2: Waitlist ControlNo interventionParticipants assigned to the waitlist control group do not receive the DRIV program during the initial 10-week study period. They continue their usual routines and complete the same assessments as the intervention group at baseline and after 10 weeks. After finishing their role as controls, they are offered participation in the DRIV program during the next available course cycle (but are not reassigned as study participants).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Physical Activity (measured by wrist-worn accelerometer)

    Physical activity intensity and duration measured using a 7-day wrist accelerometer at baseline and after the 10-week intervention. Values will be summarized as average daily minutes of moderate-to-vigorous physical activity.nt is conducted six months after the program to evaluate sustained effects.

    Measured: Baseline to 10 weeks

  2. Change in Self-Reported Lifestyle Behaviors (using standardized lifestyle questionnaire)

    Self-reported changes in diet, physical activity, sleep, stress, and tobacco/alcohol use using national public-health lifestyle indicator questions. Scores will be summarized as change from baseline.

    Measured: Baseline to 10 weeks

  3. Change in Well-Being (using the International SCI Quality of Life Basic Dataset)

    Self-reported satisfaction with general well-being, physical health, and psychological health on a 0-10 scale. Higher scores indicate better well-being. Reported as the change from baseline.

    Measured: Baseline to 10 weeks

  4. Maintenance of Lifestyle and Well-Being Improvements at 6 Months

    Sustained change in lifestyle behaviors and well-being at 6-month follow-up using the same questionnaires as above.

    Measured: 10 weeks to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start1 Aug 2025
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Participants are allocated to one of two non-randomized parallel groups. Individuals invited to participate in the immediate 10-week DRIV online health-promotion program form the intervention group. Individuals who remain on the waitlist and do not receive any intervention during the same 10-week period form the waitlist control group. After completing the control period and follow-up assessments, waitlist participants are offered the DRIV program. This design allows comparison between the intervention and control groups over an equivalent 10-week timeframe.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07473258
Sponsor's protocol ID
2023-01754-01
Other IDs
2023
Acronym
DRIV
Status last verified
Apr 2026
First submitted
17 Nov 2025
Last updated
20 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual Participant Data (IPD) will not be shared because the study involves a small and specific population-adults living with long-term spinal cord injury-making it difficult to fully anonymize the data. Sharing IPD could risk compromising participant confidentiality, especially given the sensitive nature of health-related information and the group-based format of the intervention. Additionally, the study was not designed with external data sharing in mind, and participants were not asked to consent to such sharing.

Questions about this trial

What is this clinical trial studying?

A study testing DRIV Program in people with Spinal Cord Injury, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Physical Activity (measured by wrist-worn accelerometer) (time frame: Baseline to 10 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in